Cite
HARVARD Citation
Kamal, F. et al. (2020). Tenofovir versus entecavir in prevention of hepatocellular carcinoma and mortality in patients with chronic hepatitis B. Gut. 69 (11), pp. 2054-2056. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kamal, F. et al. (2020). Tenofovir versus entecavir in prevention of hepatocellular carcinoma and mortality in patients with chronic hepatitis B. Gut. 69 (11), pp. 2054-2056. [Online].